The underlying pathophysiology of HHT involves mutations in genes such as ENG, ACVRL1, and SMAD4, which encode receptors within the transforming growth factor-beta (TGF-β) superfamily. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.